CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (14,278,439)	$ (13,028,904)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	844,438	285,730
Loss on disposal of property and equipment	208,782	0
Impairment of goodwill and intangible assets	821,741	0
Loss on extinguishment of convertible notes payable	1,774,662	0
Gain on extinguishment of notes payable	(839,945)	0
Stock-based compensation	1,668,003	1,001,082
Amortization of debt issuance costs	0	26,019
Provision for bad debts	28,629	45,280
Change in operating assets and liabilities:
Accounts receivable	(2,638,350)	600,352
Inventories	(872,566)	(354,738)
Prepaid expenses and other current assets and deposits	30,415	(27,288)
Accounts payable and accrued liabilities	94,711	427,365
Deferred revenue	(230,036)	(117,957)
Net cash used in operating activities	(13,387,955)	(11,143,059)
Cash flows from investing activities:
Purchase of intangible asset	0	0
Purchase of property and equipment	(2,548,695)	(1,063,698)
Net cash used in investing activities	(2,548,695)	(1,063,698)
Cash flows from financing activities:
Net proceeds from exercise of warrants	2,613,929	8,055,797
Net proceeds from sale of common stock	13,756,507	0
Net proceeds from sale of common stock and warrants	0	10,639,728
Repayment of convertible notes	(1,665,581)	(107,802)
Proceeds from promissory notes	0	846,789
Net cash provided by financing activities	14,704,855	19,434,512
Net increase in cash and cash equivalents	(1,231,795)	7,227,755
Cash and cash equivalents at beginning of period	7,786,743	558,988
Cash and cash equivalents at end of period	6,554,948	7,786,743
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest	0	45,354
Cash paid during period for income taxes	0	0
Non-cash investing and financing activities:
Interest paid in kind	28,329	35,625
Property and equipment acquired, and included in accounts payable	181,807	144,025
Deemed dividend-warrant repricing	0	2,842
Deferred offering costs reclassified to additional paid in capital	0	109,698
Issuance of warrants in settlement of convertible notes payable	$ 1,074,118	$ 0